https://www.selleckchem.com/pr....oducts/sch772984.htm
To demonstrate that a group of patients who are not considered candidates for organ preservation can achieve organ preservation through neoadjuvant chemotherapy + surgery and to determine if there are differences regarding organ preservation, disease-free survival (DFS), overall survival (OS), and cancer-specific survival (CSS) after comparing such group with another one undergoing standard treatment. Patients with laryngeal cancer were retrospectively analyzed and divided into two groups. Group A included patients who were initially
Like
Comment
Share
